Tetra Bio-Pharma closes $10M public offering to fund drug research
CEO Guy Chamberland told OBJ earlier this year firm is working on breakthrough treatments for sepsis and acute respiratory distress syndrome.
Skip to content
Leede Jones Gable
Ottawa drug-maker Tetra Bio-Pharma’s decade-long research effort may be poised to pay off
Product is designed to treat life-threatening conditions triggered when the body’s immune system “goes rogue” in response to infections such as COVID-19.
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
What about the First Home Savings Account?
Joelle Hall
10 essential considerations when selling your business
Gobel, Sampson & Associates Private Wealth Management
